The formation of foam due to the injection of surfactant foam in FAWAG causes significant problems in the oil well production and separation facilities. The excessive foam can lead to the reduction of the separator capacity as well as its efficiency. A defoamer is needed to break and destroy the foam in the separator. There are many commercially available defoamer agents in the market, but not all defoamers are suitable for every application. For this reason, four modified silicone-based defoamers were successfully synthesized and characterized based on the data obtained from the screening process using various commercial defoamers. The performance of modified defoamers was evaluated using TECLIS FoamScan that imitate real conditions of treatment. The results show that all four of the modified silicone-based defoamers, especially amide-terminated-modified defoamers (S2) showed excellent performance as a defoaming agent to mitigate foam in specific conditions. The best-case condition for the modified defoamer to perform was at a high temperature (60 °C), gas flow rate of 1.0 L/min, and low ration concentration of the surfactant to brine (30:70). The study on the bubble count and distribution using a KRÜSS Dynamic Foam Analyzer revealed that S2 excellently contributes to the formation of unstable foam that can fasten foam destruction in the foaming system.
Health system reforms across high- and middle-income countries often involve changes to public hospital governance. Corporatization is one such reform, in which public sector hospitals are granted greater functional independence while remaining publicly owned. In theory, this can improve public hospital efficiency, while retaining a public service ethos. However, the extent to which efficiency gains are realized and public purpose is maintained depends on policy choices about governance and payment systems. We present a case study of Malaysia's National Heart Institute (IJN), which was created in 1992 by corporatization of one department in a large public hospital. The aim of the paper is to examine whether IJN has achieved the goals for which it was created, and if so, whether it provides a potential model for further reforms in Malaysia and other similar health systems. Using a combination of document analysis and key informant interviews, we examine key governance, health financing and payment, and equity issues. For governance, we highlight the choice to have IJN owned by and answerable to a Ministry of Finance (MOF) holding company and MOF-appointed board, rather than the Ministry of Health (MOH). On financing and payment, we analyze the implications of IJN's combined role as fee-for-service provider to MOH as well as provider of care to private patients. For equity, we analyze the targeting of IJN care across publicly-referred and private patients. These issues demonstrate unresolved tensions between IJN's objectives and public service goals. As an institutional innovation that has endured for 28 years and grown dramatically in size and revenue, IJN's trajectory offers critical insights on the relevance of the hybrid public-private models for hospitals in Malaysia as well as in other middle-income countries. While IJN appears to have achieved its goal of establishing itself as a commercially viable, publicly owned center of clinical excellence in Malaysia, the value for money and equity of the services it provides to the Ministry of Health remain unclear. IJN is accountable to a small Ministry of Finance holding company, which means that detailed information required to evaluate these critical questions is not published. The case of IJN highlights that corporatization cannot achieve its stated goals of efficiency, innovation, and equity in isolation; rather it must be supported by broader reforms, including of health financing, payment, governance, and transparency, in order to ensure that autonomous hospitals improve quality and provide efficient care in an equitable way.
Several new possible biobased corrosion inhibitors derived from fatty hydrazide derivatives were analyzed using quantum chemical calculations via the density functional theory method to investigate the chemical reactivity and inhibition efficiencies against corrosion in metal steel. The study confirmed that the fatty hydrazides showed significant inhibitive performances based on their electronic properties, revealing band gap energies of 5.20 to 7.61 eV between the HOMO and LUMO. These energy differences decreased from 4.40 to 7.20 eV when combined with substituents of varying chemical compositions, structures, and functional groups, associated with higher inhibition efficiency. The most promising fatty hydrazide derivatives are terephthalic acid dihydrazide combined with a long-chain alkyl chain, which resulted in the lowest energy difference of 4.40 eV. Further inspection showed that the fatty hydrazide derivatives' inhibitive performances increased with increasing carbon chain length [from 4 (4-s-4) to 6 (6-s-6)], with a concomitant increase and decrease in hydroxyl and carbonyl groups, respectively. Fatty hydrazide derivatives containing aromatic rings also showed increased inhibition efficiencies following their contribution to improve the compounds' binding ability and adsorption on the metal surface. Overall, all data were consistent with previously reported findings, envisaging the potential of fatty hydrazide derivatives as effective corrosion inhibitors.